| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Randolph B Schiffer | |
| Ariel Miller | |||
| Hillel Pratt | |||
| P2860 | cites work | A self report measure of affective lability | Q24680227 |
| The neuropsychiatry of pathologic affect: an approach to evaluation and treatment | Q28211021 | ||
| Pathological laughter and crying: a link to the cerebellum | Q28214416 | ||
| A comparison of the binding profiles of dextromethorphan, memantine, fluoxetine and amitriptyline: treatment of involuntary emotional expression disorder | Q28240047 | ||
| Fluoxetine improves emotional incontinence | Q28244067 | ||
| The neuropsychiatry of the cerebellum - insights from the clinic | Q28245215 | ||
| Citalopram for post-stroke pathological crying | Q28249344 | ||
| Prevalence and neurobehavioral correlates of pathological laughing and crying in multiple sclerosis | Q28249819 | ||
| Pathologic laughter and crying in ALS: a search for their origin | Q28280249 | ||
| Pathological laughter and crying in patients with closed traumatic brain injury | Q28291902 | ||
| Fluoxetine as a treatment for post-stroke emotionalism | Q28293082 | ||
| Dextromethorphan Plus Ultra Low‐Dose Quinidine Reduces Pseudobulbar Affect | Q28293218 | ||
| Treatment of pathologic laughing and weeping with amitriptyline | Q28306247 | ||
| Pathologic laughter after unilateral stroke. | Q51104089 | ||
| Characteristics of responses of Golgi cells and mossy fibers to eye saccades and saccadic adaptation recorded from the posterior vermis of the cerebellum. | Q51942995 | ||
| The interaction between neuroactive steroids and the σ1 receptor function: behavioral consequences and therapeutic opportunities | Q55922778 | ||
| Sertraline in stroke-associated lability of mood | Q29031119 | ||
| Dynamics of fast and slow inhibition from cerebellar golgi cells allow flexible control of synaptic integration | Q30457456 | ||
| Evidence for topographic organization in the cerebellum of motor control versus cognitive and affective processing | Q30474917 | ||
| Cerebellar tumour presenting with pathological laughter and gelastic syncope | Q33155393 | ||
| Modulating dysfunctional limbic-cortical circuits in depression: towards development of brain-based algorithms for diagnosis and optimised treatment | Q33186724 | ||
| The primate cortico-cerebellar system: anatomy and function | Q33342809 | ||
| Prevalence and clinical correlates of pathological affective display in Alzheimer's disease | Q33734418 | ||
| Treatment of pseudobulbar affect in ALS with dextromethorphan/quinidine: a randomized trial | Q34361996 | ||
| The cerebellar cognitive affective syndrome | Q34467220 | ||
| Review of pseudobulbar affect including a novel and potential therapy | Q34563839 | ||
| Psychological associations with emotionalism after stroke | Q36319120 | ||
| Involuntary emotional expression disorder (IEED) in Parkinson's disease | Q36473096 | ||
| Pathological laughter and crying in patients with multiple system atrophy-cerebellar type | Q36732313 | ||
| Therapeutic use of dextromethorphan: key learnings from treatment of pseudobulbar affect | Q36791392 | ||
| Pathological laughing and crying : epidemiology, pathophysiology and treatment | Q37188990 | ||
| An investigation of the psychiatric aspects of disseminated sclerosis | Q37198581 | ||
| The cerebellar microcircuit as an adaptive filter: experimental and computational evidence | Q37649491 | ||
| Dextromethorphan and quinidine in adult patients with uncontrolled painful diabetic peripheral neuropathy: a 29-day, multicenter, open-label, dose-escalation study | Q39342534 | ||
| Duloxetine for pathological laughing and crying | Q43270208 | ||
| Effects of dextromethorphan/quinidine on auditory event-related potentials in multiple sclerosis patients with pseudobulbar affect | Q43278236 | ||
| Pharmacokinetics of dextromethorphan after single or multiple dosing in combination with quinidine in extensive and poor metabolizers | Q45040972 | ||
| Distinct modulatory roles of sigma receptor subtypes on glutamatergic responses in the dorsal hippocampus | Q45119878 | ||
| Stimulus-induced pathologic laughter due to basilar artery dissection | Q46572900 | ||
| Mirtazapine treatment for pathological laughing and crying after stroke | Q46766267 | ||
| Fluoxetine treatment in poststroke depression, emotional incontinence, and anger proneness: a double-blind, placebo-controlled study | Q46818777 | ||
| Pathoanatomic correlation between poststroke pathological crying and damage to brain areas involved in serotonergic neurotransmission | Q48136262 | ||
| Serotonin responsive and nonresponsive diurnal depressive mood disorders and pathological affect in thalamic infarct associated with myoclonus and blepharospasm | Q48149765 | ||
| Different responses of rat cerebellar Purkinje cells and Golgi cells evoked by widespread convergent sensory inputs | Q48533222 | ||
| Pontine infarction due to basilar artery stenosis presenting as pathological laughter | Q48779568 | ||
| Pseudobulbar affect: prevalence and quality of life impact in movement disorders. | Q48840479 | ||
| Inappropriate crying and laughing in Parkinson disease and movement disorders | Q49109094 | ||
| Exaggerated crying and tremor with a cerebellar cyst | Q50276898 | ||
| Frequency and correlates of involuntary emotional expression disorder in Parkinson's disease. | Q50716983 | ||
| Brain responses to verbal stimuli among multiple sclerosis patients with pseudobulbar affect. | Q50790366 | ||
| Management of pathologic laughter and crying in patients with locked-in syndrome: a report of 4 cases. | Q50797828 | ||
| Neuroanatomy of pseudobulbar affect : a quantitative MRI study in multiple sclerosis. | Q50802793 | ||
| Pathological laughter as an unusual manifestation of acute stroke. | Q50884709 | ||
| Randomized, controlled trial of dextromethorphan/quinidine for pseudobulbar affect in multiple sclerosis. | Q50940024 | ||
| Pathological laughing and crying following traumatic brain injury. | Q50983203 | ||
| Validation of the CNS emotional lability scale for pseudobulbar affect (pathological laughing and crying) in multiple sclerosis patients. | Q50984760 | ||
| Paroxetine versus citalopram treatment of pathological crying after brain injury. | Q51084469 | ||
| P433 | issue | 7 | |
| P921 | main subject | pseudobulbar affect | Q3508789 |
| P304 | page(s) | 1077-1088 | |
| P577 | publication date | 2011-05-03 | |
| P1433 | published in | Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders | Q15760319 |
| P1476 | title | Pseudobulbar affect: the spectrum of clinical presentations, etiologies and treatments | |
| P478 | volume | 11 |
| Q48249409 | A frontal syndrome due to a brainstem lesion |
| Q55281746 | Alleviation of Psychological Distress and the Improvement of Quality of Life in Patients With Amyotrophic Lateral Sclerosis: Adaptation of a Short-Term Psychotherapeutic Intervention. |
| Q46163587 | Altered resting-state functional activity in isolated pontine infarction patients with pathological laughing and crying |
| Q38401900 | An open-label study to assess safety, tolerability, and effectiveness of dextromethorphan/quinidine for pseudobulbar affect in dementia: PRISM II results |
| Q52595291 | Correlation between cognitive impairment during the acute phase of first cerebral infarction and development of long-term pseudobulbar affect. |
| Q38219309 | Crying and suicidal, but not depressed. Pseudobulbar affect in multiple sclerosis successfully treated with valproic acid: Case report and literature review |
| Q47371943 | Dextromethorphan-quinidine-responsive pseudobulbar affect (PBA): psychopharmacological model for wide-ranging disorders of emotional expression? |
| Q38270903 | Dextromethorphan/quinidine: a review of its use in adults with pseudobulbar affect |
| Q35943735 | Effective use of sertraline for pathological laughing after severe vasospasm due to aneurysmal subarachnoid hemorrhage: case report |
| Q33838839 | Evaluating the safety and efficacy of dextromethorphan/quinidine in the treatment of pseudobulbar affect |
| Q47840786 | Hashimoto's encephalopathy presenting as pseudobulbar palsy |
| Q53659704 | Is firstly diagnosed ALS really ALS? Results of a population-based study with long-term follow-up. |
| Q38676032 | Neuronal Dysregulation in Stroke-Associated Pseudobulbar Affect (PBA): Diagnostic Scales and Current Treatment Options |
| Q45037116 | Neuropsychological assessment in a case of adult-onset hemophagocytic lymphohistiocytosis (HLH). |
| Q53279150 | No tears in heaven: did the media create the pseudo-phenomenon "altitude-adjusted lachrymosity syndrome (AALS)"? |
| Q42176159 | Nonmedical treatment of patients with dementia. |
| Q21132546 | PRISM: a novel research tool to assess the prevalence of pseudobulbar affect symptoms across neurological conditions |
| Q64065356 | Pathological Crying and Laughing in Motor Neuron Disease: Pathobiology, Screening, Intervention |
| Q30389441 | Pathological laughing and crying in amyotrophic lateral sclerosis is related to frontal cortex function |
| Q35196901 | Persistent pseudobulbar affect secondary to acute disseminated encephalomyelitis |
| Q50589123 | Physical Examination for the Academic Psychiatrist: Primer and Common Clinical Scenarios. |
| Q37561654 | Prevalence of pseudobulbar affect symptoms and clinical correlates in nursing home residents |
| Q61806263 | Pseudobulbar Affect in Parkinsonian Disorders: A Review |
| Q34658447 | Pseudobulbar affect: prevalence and management |
| Q27315829 | Pseudobulbar laughter as a levodopa off phenomenon exacerbated by subthalamic deep brain stimulation |
| Q39065476 | Recognizing and treating pseudobulbar affect |
| Q30634431 | Review of Dextromethorphan 20 mg/Quinidine 10 mg (NUEDEXTA(®)) for Pseudobulbar Affect |
| Q58125489 | Revisiting the pathoanatomy of pseudobulbar affect: mechanisms beyond corticobulbar dysfunction |
| Q42674268 | Selective TNF inhibition for chronic stroke and traumatic brain injury: an observational study involving 629 consecutive patients treated with perispinal etanercept |
| Q92489497 | The epidemiology and pathophysiology of pseudobulbar affect and its association with neurodegeneration |
| Q28709470 | The human frontal lobes and frontal network systems: an evolutionary, clinical, and treatment perspective |
| Q52311490 | The neurobiology of human crying. |
| Q40911853 | Traumatic axonal injury and persistent emotional lability in an adolescent following moderate traumatic brain injury: A case study. |
Search more.